What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His main research concerns Surgery, Internal medicine, Oncology, Bladder cancer and Cancer.
His Surgery research is multidisciplinary, incorporating elements of Breast cancer, Carcinoma and Hazard ratio.
His Internal medicine study focuses mostly on Chemotherapy, Clinical trial, Nephrology, Testicular cancer and Survival analysis.
His work deals with themes such as Cisplatin, Vinblastine, Regimen, Multivariate analysis and Gynecology, which intersect with Oncology.
His biological study spans a wide range of topics, including Carcinoma in situ, Urinary bladder, Urology and Cystoscopy.
His Cancer study combines topics in areas such as Meta-analysis, Astrocytoma, Glioma and Loading dose.
His most cited work include:
- Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial (1070 citations)
- Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial (1029 citations)
- International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers (1009 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Oncology, Surgery, Urology and Cancer.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology.
His Oncology research is multidisciplinary, incorporating perspectives in Stage, Combination chemotherapy, Multivariate analysis and Prostate cancer.
His research combines Carcinoma and Surgery.
His Urology study integrates concerns from other disciplines, such as Mitomycin C and Epirubicin.
Richard Sylvester combines subjects such as Carcinoma in situ and Urinary system with his study of Bladder cancer.
He most often published in these fields:
- Internal medicine (47.64%)
- Oncology (35.73%)
- Surgery (33.93%)
What were the highlights of his more recent work (between 2012-2021)?
- Bladder cancer (21.35%)
- Urology (24.49%)
- Internal medicine (47.64%)
In recent papers he was focusing on the following fields of study:
Richard Sylvester mainly investigates Bladder cancer, Urology, Internal medicine, Surgery and Oncology.
His Bladder cancer research is multidisciplinary, relying on both Stage, Carcinoma in situ, Nomogram and Intensive care medicine.
His Urology research includes themes of Meta-analysis, Proportional hazards model, Nephrectomy, Cystectomy and Urothelial carcinoma.
He has researched Surgery in several fields, including Cancer, Lymphadenectomy and Hazard ratio.
He interconnects Toxicity and Confidence interval in the investigation of issues within Cancer.
His study in Chemotherapy is interdisciplinary in nature, drawing from both Lung cancer and Carcinoma.
Between 2012 and 2021, his most popular works were:
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 (845 citations)
- European guidelines on upper tract urothelial carcinomas: 2013 update. (349 citations)
- Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. (294 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
